Sánchez Pérez I - Search Results

1

The role of the NFkappaB signalling pathway in cancer.

Cortés Sempere M, Rodríguez Fanjul V, Sánchez Pérez I, Perona R. Cortés Sempere M, et al. Among authors: sanchez perez i. Clin Transl Oncol. 2008 Mar;10(3):143-7. doi: 10.1007/s12094-008-0171-3. Clin Transl Oncol. 2008. PMID: 18321816 Review.

2

Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins.

Perona R, Montaner S, Saniger L, Sánchez-Pérez I, Bravo R, Lacal JC. Perona R, et al. Among authors: sanchez perez i. Genes Dev. 1997 Feb 15;11(4):463-75. doi: 10.1101/gad.11.4.463. Genes Dev. 1997. PMID: 9042860 Free article.

3

Cisplatin induces a persistent activation of JNK that is related to cell death.

Sánchez-Perez I, Murguía JR, Perona R. Sánchez-Perez I, et al. Oncogene. 1998 Jan 29;16(4):533-40. doi: 10.1038/sj.onc.1201578. Oncogene. 1998. PMID: 9484843

4

Lack of c-Jun activity increases survival to cisplatin.

Sánchez-Pérez I, Perona R. Sánchez-Pérez I, et al. FEBS Lett. 1999 Jun 18;453(1-2):151-8. doi: 10.1016/s0014-5793(99)00690-0. FEBS Lett. 1999. PMID: 10403393 Free article.

5

CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin.

Sánchez-Pérez I, Martínez-Gomariz M, Williams D, Keyse SM, Perona R. Sánchez-Pérez I, et al. Oncogene. 2000 Oct 26;19(45):5142-52. doi: 10.1038/sj.onc.1203887. Oncogene. 2000. PMID: 11064451

6

Cell stress and MEKK1-mediated c-Jun activation modulate NFkappaB activity and cell viability.

Sánchez-Pérez I, Benitah SA, Martínez-Gomariz M, Lacal JC, Perona R. Sánchez-Pérez I, et al. Mol Biol Cell. 2002 Aug;13(8):2933-45. doi: 10.1091/mbc.e02-01-0022. Mol Biol Cell. 2002. PMID: 12181357 Free PMC article.

7

Growth hormone protects against radiotherapy-induced cell death.

Madrid O, Varea S, Sanchez-Perez I, Gomez-Garcia L, De Miguel E, Gomez De Segura IA, Perona R. Madrid O, et al. Among authors: sanchez perez i. Eur J Endocrinol. 2002 Oct;147(4):535-41. doi: 10.1530/eje.0.1470535. Eur J Endocrinol. 2002. PMID: 12370117 Free article.

8

The immunosuppressant FK506 uncovers a positive regulatory cross-talk between the Hog1p and Gcn2p pathways.

Rodriguez-Hernandez CJ, Sanchez-Perez I, Gil-Mascarell R, Rodríguez-Afonso A, Torres A, Perona R, Murguia JR. Rodriguez-Hernandez CJ, et al. Among authors: sanchez perez i. J Biol Chem. 2003 Sep 5;278(36):33887-95. doi: 10.1074/jbc.M305220200. Epub 2003 Jun 17. J Biol Chem. 2003. PMID: 12813040 Free article.

9

The antidiabetic agent sodium tungstate activates glycogen synthesis through an insulin receptor-independent pathway.

Domínguez JE, Muñoz MC, Zafra D, Sanchez-Perez I, Baqué S, Caron M, Mercurio C, Barberà A, Perona R, Gomis R, Guinovart JJ. Domínguez JE, et al. Among authors: sanchez perez i. J Biol Chem. 2003 Oct 31;278(44):42785-94. doi: 10.1074/jbc.M308334200. Epub 2003 Aug 18. J Biol Chem. 2003. PMID: 12925525 Free article.

10

Control of oncogenesis and cancer therapy resistance.

Perona R, Sánchez-Pérez I. Perona R, et al. Among authors: sanchez perez i. Br J Cancer. 2004 Feb 9;90(3):573-7. doi: 10.1038/sj.bjc.6601552. Br J Cancer. 2004. PMID: 14760366 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

121 results

Search Page